Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 52.00
-0.20 (-0.38%)
At close: Feb 26, 2026
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €832.63 million as of February 26, 2026. Its market cap has increased by 52.74% in one year.
Market Cap
832.63M
Enterprise Value
856.31M
Revenue
296.76M
Ranking
n/a
PE Ratio
20.57
Stock Price
€52.00
Market Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 832.63M, an increase of 125.32%. That is a compound annual growth rate of 4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 835.83M | 5.03% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.63B |
| Laboratorios Farmaceuticos Rovi | 4.20B |
| Almirall | 2.76B |
| Faes Farma | 1.56B |
| Pharma Mar | 1.37B |
| Oryzon Genomics | 250.75M |
| Atrys Health | 231.42M |
| Prim, S.A. | 218.66M |